June 2016

Blueprint Bio, Inc., a company dedicated to identifying, validating, protecting, publishing and licensing new biological discoveries in the healthcare industry, has announced that Edward Jensen will be joining the executive team, effective immediately. He will assume the position of Chief Operating Officer and will be responsible for all strategic operations and execution.

Blueprint Bio, a company dedicated to identifying, protecting and offering new biological discoveries to the medical community, has closed its Series A funding round, according to CEO and co-founder Matthew Nunez.

Forentis Fund, a $50 million special purpose venture fund focused on biotechnology, has committed to provide $7.5 million in funding to Blueprint Bio, Inc., the first of the company’s target portfolio companies to receive a funding commitment.

Forentis Partners, LLC has announced that Forentis Fund, a $50 million special purpose venture fund focused on biotechnology and precision medicine, has received its first institutional investment commitment. The fund has received a commitment letter from Single Oak Ventures for $5 million.

The Genomic Data Commons (GDC), a unified data system that promotes sharing of genomic and clinical data between researchers, launched today with a visit from Vice President Joe Biden to the operations center at the University of Chicago.